Welcome to our dedicated page for Bolt Projects Holdings SEC filings (Ticker: BSLK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page compiles U.S. SEC filings for Bolt Projects Holdings, Inc. (Nasdaq: BSLK), a biomaterials company focused on the beauty and personal care industry. Through these documents, investors can review how the company reports on its Vegan Silk™ Technology Platform, capital structure, governance, and Nasdaq listing status.
Bolt Projects’ filings include Current Reports on Form 8-K, which disclose material events such as preliminary financial results, quarterly business updates, amendments to bylaws, equity financing arrangements, and notices related to Nasdaq listing compliance. For example, 8-K filings reference preliminary revenue and gross margin expectations, financing term sheets and equity line of credit agreements, and Nasdaq determinations regarding market value and equity listing standards.
The company also files registration statements, such as a Form S-1, describing equity line of credit facilities and the potential resale of common stock by a selling stockholder. These documents outline the terms of financing arrangements, risk factors, and Bolt Projects’ status as an emerging growth company and smaller reporting company. Proxy materials, including a Definitive Proxy Statement on Schedule 14A, provide information on matters submitted to stockholders, such as approvals related to convertible notes and warrants and adjournment proposals for special meetings.
Over time, investors can use annual reports on Form 10-K and quarterly reports on Form 10-Q (when available) to analyze segment information, revenue sources from the Vegan Silk platform, research and development spending, and liquidity and capital resources. Insider transaction reports on Form 4, when filed, offer visibility into equity transactions by directors and officers.
On Stock Titan, Bolt Projects’ SEC filings are updated as they are posted to EDGAR and are accompanied by AI-powered summaries that highlight key points, such as changes in guidance, new financing commitments, or updates to governance documents. These tools help readers quickly understand lengthy filings, compare successive reports, and identify disclosures related to listing compliance, equity facilities, and the company’s biomaterials-focused business model.
Bolt Projects Holdings, Inc. received an amended Schedule 13G showing that an investor group led by Ascent Partners Fund LLC now beneficially owns 228,408 shares of common stock, or 4.97% of the company. This Amendment No. 1 is described as an exit filing because the group no longer holds more than 5%.
The 228,408 shares were issued to Ascent as payment adjustment shares under an equity purchase agreement dated September 12, 2025. The filing notes that total common shares outstanding were 4,594,531 as of December 31, 2025, and that the company was delisted from Nasdaq on January 5, 2026, after which it could no longer draw on the equity facility.
Bolt Projects Holdings, Inc. filed a current report to share that it announced its preliminary expected results for the fourth quarter and full year 2025 and updated its full year fiscal 2026 guidance on December 29, 2025. The details of these early results and the revised outlook are contained in a press release that is furnished as Exhibit 99.1 and incorporated by reference.
The company notes that this information is being furnished under Regulation FD rather than filed, which affects how it is treated under securities laws but still gives investors an early view of recent performance trends and expectations for fiscal 2026.
Bolt Projects Holdings, Inc. has filed a prospectus supplement that incorporates its Quarterly Report for the period ended September 30, 2025, updating investors on its business and financial condition. The company develops biomaterials, led by its Vegan Silk Technology Platform for beauty and personal care products.
For the quarter, Bolt generated revenue of $370 (in thousands) and reported a net loss of $7,478 (in thousands). For the nine-month period, revenue reached $1,843 (in thousands) with a net loss of $18,020 (in thousands), reflecting ongoing operating losses and interest expense on debt. Cash and cash equivalents were $4,745 (in thousands), while long-term debt totaled $12,000 (in thousands).
Management states there is substantial doubt about the company’s ability to continue as a going concern over the next year, citing a cumulative deficit of $479,821 (in thousands), negative working capital of $3,323 (in thousands), and the need to raise additional capital or restructure debt. The supplement also notes a 1-for-20 reverse stock split and ongoing reliance on a small number of customers and a single key manufacturing partner.
Bolt Projects Holdings (BSLK) reported an insider stock transaction by its General Counsel and Secretary. On 11/19/2025, the executive sold 819 shares of common stock at $1.66 per share. The filing notes that this sale was made to cover taxes due upon the vesting and settlement of restricted stock units, rather than as an open-market liquidation of a larger position.
After this tax-related sale, the executive beneficially owned 1,181 shares of Bolt Projects common stock in direct ownership. The company previously completed a 1-for-20 reverse stock split on April 21, 2025, and all share amounts in this disclosure have been adjusted to reflect that reverse split.
Bolt Projects Holdings, Inc. (BSLK) reported an insider transaction: the Interim CFO received 17,672 restricted stock units of common stock on 11/12/2025. The RSUs were fully vested at the date of grant and recorded at a price of $0.
Following the award, the reporting person beneficially owns 72,976 shares on a direct basis. The filing was submitted by one reporting person and reflects a routine equity grant under the company’s equity incentive plan.
Bolt Projects Holdings, Inc. (BSLK) reported Q3 2025 results. Revenue rose to $370 thousand from $5 thousand a year ago, producing gross income of $58 thousand. Operating expenses were $4.4 million, leading to a loss from operations of $4.4 million and a net loss of $7.5 million for the quarter. For the nine months, revenue was $1.8 million and net loss was $18.0 million.
Cash and cash equivalents were $4.7 million at September 30, 2025. The company reported negative net working capital of $3.3 million, long‑term debt of $12.9 million, and a stockholders’ deficit of $12.7 million. Management states that these conditions raise substantial doubt about the company’s ability to continue as a going concern.
The company effected a 1‑for‑20 reverse stock split on April 21, 2025. Shares outstanding were 3,706,197 at September 30, 2025; as of November 7, 2025, shares outstanding were 4,366,123. Warrants remain outstanding, and fair‑value remeasurements affected other income/expense during the period.
Bolt Projects Holdings, Inc. filed a current report outlining that it has released financial results for the three months ended September 30, 2025 and shared a business update. The company reported these details through a press release dated November 12, 2025.
The press release is included as Exhibit 99.1 and is described as being furnished rather than filed, which means it is not subject to certain liability provisions of the securities laws and will only be incorporated into other documents if explicitly stated. The filing also notes the company’s common stock and warrants trade on The Nasdaq Stock Market under the symbols BSLK and BSLKW, respectively.
Bolt Projects Holdings (BSLK) is asking stockholders to approve, under Nasdaq Listing Rule 5635(d), the issuance of the maximum number of common shares issuable upon conversion of secured convertible notes and the exercise of related warrants expected to be issued to Murchinson Ltd. The company describes a proposed up to $30 million 10% original issue discount convertible note financing to support working capital, including repayment of amounts owed to secured creditor Ginkgo Bioworks. The notes would bear 2.00% interest and mature 12 months from issuance, with equal monthly redemptions of 1/12th of the initial balance in cash or, subject to conditions, shares.
The structure contemplates an initial draw sized by formula and additional tranches subject to conditions, including trading volume and market capitalization thresholds. If paid in shares, the conversion price would be the lower of 115% of the price immediately preceding the initial closing or 90% of the lowest VWAP in the five trading days before each conversion. Warrants equal to 20% of principal divided by the initial conversion price would accompany the notes with a 3‑year term. The Board recommends voting FOR Proposal 1 and FOR adjournment authority if needed. If approved, existing holders face dilution and potential market pressure from resales. If not approved, the company states it cannot consummate the financing, would receive no proceeds, and that failure may impair its ability to continue as a going concern and could impact its Nasdaq listing. Holders of record as of October 20, 2025 (4,084,493 shares outstanding) may vote at the virtual meeting on December 3, 2025.
Bolt Projects Holdings (BSLK) furnished an 8‑K to announce a press release with business updates and preliminary, unaudited financial information for the quarter ended September 30, 2025. The press release is included as Exhibit 99.1 and incorporated by reference.
The company notes that the information under Item 2.02, including Exhibit 99.1, is being furnished, not filed under the Exchange Act. This distinction limits its use for certain liability purposes and incorporation into Securities Act filings unless expressly stated.
Bolt Projects Holdings, Inc. filed Prospectus Supplement No. 10 under Rule 424(b)(3) to update its March 27, 2025 prospectus by incorporating the company’s Form 8‑K filed on October 17, 2025. The 8‑K reports that the Board approved and adopted amendments to the company’s Amended and Restated Bylaws, effective October 17, 2025. The full text of the amended bylaws is provided as Exhibit 3.1. The supplement is intended to be read together with the existing prospectus.